A Novel Heterozygous KCNH2 c.1288G > C (p.A430P) Variant Causes Type 2 Long QT Syndrome Through Loss of hERG Channel Function
Molecular Genetics & Genomic Medicine · 2026-11 · 14 (11)
DOI: 10.1002/mgg3.70325 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 16.11.2026. Verfasst von Cen Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: ERG1 Potassium Channel, Long QT Syndrome, Mutation, Missense, Loss of Function Mutation. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Provincial Science and Technology Innovation Joint Fund Project, Talent Introduction Program of The First Affiliated Hospital of Fujian Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
A novel variant in the KCNH2 gene (human ether‐a‐go‐go‐related gene, hERG) has been identified and is associated with type 2 long QT syndrome (LQT2). Integrating genotype analysis into clinical evaluation facilitates more accurate diagnosis and targeted therapeutic strategies for this condition.
Method
Sanger sequencing was used to detect the KCNH2 variant in an LQT2 family. The variant was transiently expressed in HEK293 cells for functional characterization via patch‐clamp electrophysiology, Western blot, and qRT‐PCR.
Result
A novel heterozygous missense variant KCNH2 c.1288G > C (p.Ala430Pro) was identified. Unlike wild‐type (WT) channels, the A430P variant generated no detectable hERG currents. Western blot showed comparable protein expression between WT and A430P, both migrating at approximately 127 kDa, which corresponds to the core‐glycosylated form. qRT‐PCR revealed significantly elevated A430P mRNA levels compared to WT ( p = 0.0027).
Conclusion
The complete loss of channel function in the A430P variant is not due to reduced protein expression. The discordance between elevated mRNA and unchanged protein levels suggests post‐transcriptional or translational dysregulation, expanding our understanding of LQT2 molecular mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
- Department of Cardiology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
- The Higher Educational Key Laboratory for Cardiovascular Disease of Fujian Province, Clinical Research Center for Metabolic Heart Disease of Fujian Province, The First Affiliated Hospital, Fujian Medical University, Fuz…
- Department of Medical Genetics, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
- Molecular Medicine of Jiangxi Key Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
ORCID-Profile: Cen Wang, DaJun Chai
Förderung
- Fujian Provincial Science and Technology Innovation Joint Fund Project
- Talent Introduction Program of The First Affiliated Hospital of Fujian Medical University
- National Natural Science Foundation of China
- Fujian Provincial Health Technology Project
Zitieren
APA
Wang, C., Shen, Y., Li, Q., & Chai, D. (2026). A Novel Heterozygous KCNH2 c.1288G > C (p.A430P) Variant Causes Type 2 Long QT Syndrome Through Loss of hERG Channel Function. Molecular Genetics & Genomic Medicine, 14(11). https://doi.org/10.1002/mgg3.70325
Vancouver
Wang C, Shen Y, Li Q, Chai D. A Novel Heterozygous KCNH2 c.1288G > C (p.A430P) Variant Causes Type 2 Long QT Syndrome Through Loss of hERG Channel Function. Molecular Genetics & Genomic Medicine. 2026;14(11). doi:10.1002/mgg3.70325
BibTeX
@article{Wang2026,
author = {Wang, Cen and Shen, Yang and Li, QingQing and Chai, DaJun},
title = {A Novel Heterozygous KCNH2 c.1288G > C (p.A430P) Variant Causes Type 2 Long QT Syndrome Through Loss of hERG Channel Function},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
volume = {14},
number = {11},
doi = {10.1002/mgg3.70325}
}
EUVIMED